The applicability of urinary creatinine as a method of specimen normalization in the cystic fibrosis population

Brandie D. Wagner, Frank J. Accurso, Theresa A. Laguna

Research output: Contribution to journalArticle

29 Scopus citations

Abstract

Background: Urine specimens are commonly used in biomarker research. Urinary creatinine (UCr) is often used to adjust for urine analyte concentration. We aim to explore the applicability of UCr as a normalization method in a cystic fibrosis (CF) population during hospitalization. Methods: Multiple spot urine samples were collected from CF patients hospitalized for a pulmonary exacerbation. Single spot specimens were obtained from asthmatics and healthy children for comparison. The assumptions and implications from the use of UCr as a normalization factor for urinary desmosine measurements were investigated. Results: UCr differed significantly across disease groups and decreased significantly over time in the CF population. Differing results were obtained when contrasting normalization by UCr with specific gravity. Conclusions: UCr levels are not completely attributable to simply variations in urine concentration. Analysis of urinary biomarker measurements should be initiated with an understanding of the relative effects of the normalization process on the results.

Original languageEnglish (US)
Pages (from-to)212-216
Number of pages5
JournalJournal of Cystic Fibrosis
Volume9
Issue number3
DOIs
StatePublished - May 1 2010

Keywords

  • Cystic fibrosis
  • Normalization factor
  • Pulmonary exacerbation
  • Specific gravity
  • Urinary biomarkers
  • Urinary creatinine

Fingerprint Dive into the research topics of 'The applicability of urinary creatinine as a method of specimen normalization in the cystic fibrosis population'. Together they form a unique fingerprint.

Cite this